Bluebird Bio vs Rocket Pharmaceuticals
Bluebird Bio vs Rocket Pharmaceuticals, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bluebird Bio is on 51/100 and Rocket Pharmaceuticals on 57/100.
Where each one leads
Bluebird Bio
- agent readiness: 46/100 against 40/100
- headcount: 137 against 100
- funding raised: $1.0B against $383M
Rocket Pharmaceuticals
- our overall score: 57/100 against 51/100
At a glance
| Measure | Bluebird Bio | Rocket Pharmaceuticals |
|---|---|---|
| What it is | Gene therapy company developing transformative treatments for severe genetic diseases. | A biotechnology company developing genetic therapies for rare disorders. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotechnology, Pharmaceuticals, Healthcare, Genetics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 1992 | 2015 |
| Headquarters | Somerville, United States | Cranbury, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Bluebird Bio | Rocket Pharmaceuticals |
|---|---|---|
| Employees | 137 | 100 |
| Open roles | 16 | Not published |
| Total funding | $1.0B | $383M |
| Latest round | Series D | Acquisition |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 141,691 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bluebird Bio | Rocket Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 57/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 25/100 | 14/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 52/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bluebird Bio | Rocket Pharmaceuticals |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
Bluebird Bio vs Rocket Pharmaceuticals: common questions
Which is better, Bluebird Bio or Rocket Pharmaceuticals?
On our 0-100 score Rocket Pharmaceuticals rates higher (57/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Bluebird Bio and Rocket Pharmaceuticals compare on the numbers?
Bluebird Bio leads on agent readiness (46/100 against 40/100), headcount (137 against 100), funding raised ($1.0B against $383M). Rocket Pharmaceuticals leads on our overall score (57/100 against 51/100).
Read the full Bluebird Bio review and pricing or the Rocket Pharmaceuticals review and pricing. You can also browse other Bluebird Bio alternatives we track.